Skip to main content
. 2021 Apr 15;8:635337. doi: 10.3389/fmolb.2021.635337

TABLE 2.

List of viral vector–based vaccine candidates under preclinical evaluation (WHO, 2021).

Developer/manufacturer Type of vaccine candidate
Nonreplicating viral vector–based vaccine candidates
 University of Helsinki/University of Eastern Finland Ad 5 vector
 Theravectys-Institut Pasteur Lentiviral vector
 ID Pharma Sendai virus vector
 Ankara University Adenovirus-based
 Massachusetts General Hospital/AveXis AAVCOVID
 GeoVax/BravoVax MVA-encoded VLP
 DZIF- German Center for Infection Research/DT Biologika GmbH MVA-S encoded
 IDIBAPS-Hospital Clinic (Spain) MVA-S
 AIOVA Lentiviral vector
 Erciyes University Adeno5-based
 Greffex Ad5 S
 Stabilitech Biopharma Ltd Oral Ad5 S
 Valo Therapeutics Ltd Adenovirus-based + HLA-matched peptides
 Centro Nacional Biotecnologia (CNB-CSIC) (Spain) MVA expressing structural proteins
 University of Georgia/University of Lowa PIV5
 Bharat Biotech/Thomas Jefferson University Recombinant deactivated rabies virus containing S1
 National Research Center (Egypt) Influenza a H1N1 vector
 Icahn School of Medicine at Mount Sinai Newcastle disease virus expressing S
 Vaxart Oral vaccine platform
 Sorbonne University Lentiviral vector Retro-VLP particles
Replicating viral vector–based vaccine candidates
 Farmacologicos Veterinarios SAC (FARVET SAC)/Universidad Peruana Cayetano Heredia (UPCH) rNDV-FARVET expressing RBD
 KU Leuven YF17D vector
 Cadila Healthcare Limited Measles vector
 FBRI SRS VB VECTOR, Rospotrebnadzor, Koltsovo Measles vector
 CanVirex AG/DZIF- German Center for Infection Research Measles virus (S, N targets)
 Tonix Pharma/Southern Research Horsepox vector expressing S protein
 BiOCAD/IEM Attenuated influenza virus based live viral vectored vaccine
 FBRI SRC VB VECTOR, rospotrebnadzor, Koltsovo Influenza–based recombinant vaccine
 Instituto Buntantan/Fundacao Oswaldo Cruz Attenuated influenza expressing an antigenic portion of the spike protein
 University of Hong Kong Influenza vector expressing RBD
 University of Manitoba Replicating VSV vector–based DC-targeting
 University of Western Ontario VSV-S
 Aurobindo VSV-S
 FBRI SRC VB VECTOR, Rospotrebnadzor, Koltsovo VSV vector
 UW-Madison, Bharat Biotech and FluGen M2SR influenza vector
 Intravacc, Utrecht University, Wageningen Bioveterinary Research NDV-SARS-CoV-2/Spike
 The Lancaster University (United Kingdom) APMV
 Farvet SAC rNDV-LS1-HN-RBD/SARS-CoV-2
 Farvet SAC rNDV-LS1-S1-F/SARS-CoV-2